ADVANCED UNRESECTABLE MELANOMA

Clinical trials for ADVANCED UNRESECTABLE MELANOMA explained in plain language.

Never miss a new study

Get alerted when new ADVANCED UNRESECTABLE MELANOMA trials appear

Sign up with your email to follow new studies for ADVANCED UNRESECTABLE MELANOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New hope for Tough-to-Treat skin cancer?

Disease control Recruiting now

This study is testing a drug called mirdametinib for people with advanced melanoma that has a specific genetic change (NF1 mutation) and has continued to grow despite standard immunotherapy. The main goals are to see if the drug is safe and if it can help control the cancer. It's…

Matched conditions: ADVANCED UNRESECTABLE MELANOMA

Phase: PHASE2 • Sponsor: Kevin Kim, MD • Aim: Disease control

Last updated Mar 02, 2026 15:22 UTC

ADVANCED UNRESECTABLE MELANOMA

Get alerted when new ADVANCED UNRESECTABLE MELANOMA trials appear

New hope for Tough-to-Treat skin cancer?